ArticleScientifica2026
Preparation and Evaluation of Niosomal
Article in Scientifica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preparation and Evaluation of NiosomalScientifica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The pain and suffering of patients with hemorrhoids are strongly impacted by the inadequacy of available treatment options, with more severe cases facing suboptimal outcomes. Owing to its known properties, the traditional Thai medicine Methods: To validate and scrutinize the extent of the therapeutic effects of CSM, we compared two drying techniques: a dehydration chamber and a hot air oven. Analysis of computational biology, otherwise known as "network pharmacology," was employed to hypothesize and validate key pharmacological targets and investigate the toxicity and anti-inflammatory properties of CSM in L929 and RAW 264.7 cells. Furthermore, this study presents the development of a niosome-based enhanced therapeutic delivery formulation for CSM. Results and Discussion: Inhibiting the production of nitric oxide (NO) demonstrated that CSM dehydration performed in the dehydration chamber resulted in an IC Conclusions: The data indicate that CSM extract, especially when dehydrated in a dehydration chamber and then encapsulated in niosomes, has the potential to serve as a safe and effective therapeutic for hemorrhoids. The findings also emphasize the role of the drying method in retaining the bioactivity of plant extracts and the need for niosomes as a delivery system to improve bioavailability.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.